Literature DB >> 11254896

The impact of phospholipid transfer protein (PLTP) on HDL metabolism.

J Huuskonen1, V M Olkkonen, M Jauhiainen, C Ehnholm.   

Abstract

High-density lipoproteins (HDL) play a major protective role against the development of coronary artery disease. Phospholipid transfer protein (PLTP) is a main factor regulating the size and composition of HDL in the circulation and plays an important role in controlling plasma HDL levels. This is achieved via both the phospholipid transfer activity of PLTP and its capability to cause HDL conversion. The present review focuses on the impact of PLTP on HDL metabolism. The basic characteristics and structure of the PLTP protein are described. The two main functions of PLTP, PLTP-mediated phospholipid transfer and HDL conversion are reviewed, and the mechanisms and control, as well as the physiological significance of these processes are discussed. The relationship between PLTP and the related cholesteryl ester transfer protein (CETP) is reviewed. Thereafter other functions of PLTP are recapitulated: the ability of PLTP to transfer cholesterol, alpha-tocopherol and lipopolysaccharide (LPS), and the suggested involvement of PLTP in cellular cholesterol traffic. The discussion on PLTP activity and mass in (patho)physiological settings includes new data on the presence of two forms of PLTP in the circulation, one catalytically active and the other inactive. Finally, future directions for PLTP research are outlined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254896     DOI: 10.1016/s0021-9150(01)00447-6

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  53 in total

Review 1.  Reverse cholesterol transport: high-density lipoprotein's magnificent mile.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 2.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.

Authors:  Andrew A Francis; Grant N Pierce
Journal:  Exp Clin Cardiol       Date:  2011

Review 4.  Molecular regulation of HDL metabolism and function: implications for novel therapies.

Authors:  Daniel J Rader
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

Review 5.  HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease.

Authors:  H Bryan Brewer
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

6.  Ataxia with vitamin E deficiency with a mutation in a phospholipid transfer protein gene.

Authors:  Satoshi Kono; Akiko Otsuji; Hiroaki Hattori; Kentaro Shirakawa; Hitoshi Suzuki; Hiroaki Miyajima
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

7.  Novel changes in discoidal high density lipoprotein morphology: a molecular dynamics study.

Authors:  Andrea Catte; James C Patterson; Martin K Jones; W Gray Jerome; Denys Bashtovyy; Zhengchang Su; Feifei Gu; Jianguo Chen; Marcela P Aliste; Stephen C Harvey; Ling Li; Gilbert Weinstein; Jere P Segrest
Journal:  Biophys J       Date:  2006-03-31       Impact factor: 4.033

8.  An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese.

Authors:  Keisuke Shioji; Toshifumi Mannami; Yoshihiro Kokubo; Yoichi Goto; Hiroshi Nonogi; Naoharu Iwai
Journal:  J Hum Genet       Date:  2004-07-17       Impact factor: 3.172

9.  Genetics of non-conventional lipoprotein fractions.

Authors:  Alexis C Frazier-Wood
Journal:  Curr Genet Med Rep       Date:  2015-08-29

10.  Haptoglobin inhibits phospholipid transfer protein activity in hyperlipidemic human plasma.

Authors:  Ryan J Henderson; Kishor M Wasan; Carlos G Leon
Journal:  Lipids Health Dis       Date:  2009-07-23       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.